2001
Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy
Holman R, Paddock C, Curns A, Krebs J, McQuiston J, Childs J. Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy. The Journal Of Infectious Diseases 2001, 184: 1437-1444. PMID: 11709786, DOI: 10.1086/324372.Peer-Reviewed Original ResearchConceptsRisk factorsFatal Rocky Mountain Spotted FeverRocky Mountain Spotted FeverOnset of symptomsCase fatality rateTetracycline-class antibioticsPrimary therapyClinical characteristicsOlder patientsAppropriate therapyRMSF casesNonfatal casesNational surveillanceHigh riskSpotted FeverPatientsEffective antibioticsTherapyDeathFeverAntibioticsTreatmentSymptomsFactorsDisease
1998
An epidemiologic and entomologic investigation of a cluster of Rocky Mountain spotted fever cases in Delaware.
Rotz L, Callejas L, McKechnie D, Wolfe D, Gaw E, Hathcock L, Childs J. An epidemiologic and entomologic investigation of a cluster of Rocky Mountain spotted fever cases in Delaware. Delaware Medical Journal 1998, 70: 285-91. PMID: 9662871.Peer-Reviewed Original ResearchConceptsEntomologic investigationsMore symptomsTick-borne illnessCases of RMSFHealth care providersSerologic evaluationMedian ageRMSF casesClinical aspectsCare providersFever casesDelaware DivisionDisease controlFeverPatientsSymptomsTwo-week periodPrevention measuresPublic healthIllnessRiskRMSFHeadacheAttendeesYears